| Literature DB >> 33937512 |
Rayan Saade1, Tyler Tsang2, Michel Kmeid1, David Miller2, Zhiyan Fu1, James Litynski3, Patrick Young4, Joseph C Anderson5,6, Hwajeong Lee1, Micheal Tadros3.
Abstract
Background and study aims Adequate removal of precancerous polyps is an independent factor in colorectal cancer prevention. Despite advances in polypectomy techniques, there is an increasing rate of surgery for benign polyps. We assessed whether surgical resection is properly utilized for benign colorectal polyps. Patients and methods We identified 144 patients with surgical resection for benign colorectal polyps. Polyp location, size and the indication for and type of surgery were obtained. For the purposes of this analysis, we assumed that gastroenterologists should assess polyp size accurately, endoscopically resect polyps < 2 cm, and treat incompletely excised polyps on follow-up. Results A total of 118 patients (82 %) were referred to surgery without attempted endoscopic removal. In 26 (22 %) of 118, the macroscopic polyp size was < 2 cm (23 in right, 3 in the left colon) and 18 (15 %; 14 in the right, four in the left colon) were found to have had size overestimation during endoscopy. Twenty-two (15 %) of 144 underwent surgical resection for incomplete endoscopic resection of adenomas (16 in the right, 6 in the left colon); 12 (54.5 %) had a residual polyp size of < 2 cm (10 in the right colon; 2 in the left colon). In-hospital mortality was 0.7 % and morbidity was 20.1 %. Conclusions Of the patients, 41 % could have potentially avoided surgical intervention (37 polyps < 2 cm and/or size overestimations precluding endoscopic polypectomy and 22 incomplete resections). When including polyps with size ≥ 2 to < 4 cm, the percentage of patients with avoidable surgery reached 80 %. This confirms the need to develop standardized quality metrics for endoscopic polypectomies and for better overall training of endoscopists performing these procedures. Given the risks of surgery, referral to an experienced gastroenterologist should be considered as a first step. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).Entities:
Year: 2021 PMID: 33937512 PMCID: PMC8062229 DOI: 10.1055/a-1380-3017
Source DB: PubMed Journal: Endosc Int Open ISSN: 2196-9736
Fig. 1Patient identification flow chart
Patient demographics.
| N = 144 | |
| Age (years), mean (range) | 65 (34–94) |
| Gender, n (%) | |
Male | 77 (53.5 %) |
Female | 67 (46.5 %) |
| Diabetes mellitus, n (%) | 29 (20 %) |
| Hyperlipidemia, n (%) | 69 (48 %) |
| Hypertension, n (%) | 74 (51 %) |
| Smoking, n (%) | 70 (49 %) |
| Body mass index (kg/m 2 ), median (range) | 26.9 (16.4–46.9) |
Surgical referral patterns.
| N = 144 | |
| No attempted endoscopic polypectomy, n (%) | 118 (82 %) |
| Polyp < 2 cm, n (%) | 26 (18 %) |
Right colon | 23 (16 %) |
Left colon | 3 (2 %) |
| Polyp ≥ 2 cm, n (%) | 92 (64 %) |
Right colon | 66 (46 %) |
Left colon | 26 (18 %) |
| Polyp ≥ 2 cm – < 4 cm | 56 (39 %) |
| Polyp ≥ 4 cm | 36 (25 %) |
| Size overestimation, n (%) | 18 (13 %) |
| Polyp < 2 cm with size overestimation, n (%) | 7 (5 %) |
| Polyp ≥ 2 cm with size overestimation, n (%) | 11 (8 %) |
| Incomplete endoscopic resection, n (%) | 22 (15 %) |
| Residual polyp < 2 cm, n (%) | 12 (8 %) |
Right colon | 10 (7 %) |
Left colon | 2 (1 %) |
| Residual polyp ≥ 2 cm, n (%) | 10 (7 %) |
Right colon | 6 (4 %) |
Left colon | 4 (3 %) |
| Serrated polyposis or multiple polyposis syndromes, n (%) | 4 (3 %) |
Surgical adverse events.
|
| |
| Hospital stay (days), median (range) | 4.5 (3.0–14.0) |
| Patients admitted to the intensive care unit, n (%, 95 % CI) | 9 (6.3 %;3.3–11.5) |
| Intensive care unit stay (days), median (range) | 3.0 (1.0–10.5) |
| Patients with postoperative adverse events, n (%, 95 % CI) | 29 (20.1 %; 14.4–27.4) |
| Postoperative adverse events type, n (%, 95 % CI) | |
Postprocedural bleeding | 4 (2.8 %;1.1–6.9) |
Wound infection | 4 (2.8 %1.1–6.9) |
Ileus | 11 (7.6 %) |
Anastomotic leakage | 2 (1.4 %) |
Urinary tract infection | 3 (2.1 %; 0.7–6.0) |
Pneumonia | 1 (0.7 %; 0.1–3.8) |
Sepsis | 3 (2.1 %; 0.7–6.0) |
Deep vein thrombosis | 1 (0.7 %; 0.1–3.8) |
| Mortality, n (%, 95 % CI) | 1 (0.7 %; 0.1–3.8) |